News & Updates
Filter by Specialty:
Older age at first screening colonoscopy linked to higher risk of adenomas, CRC
At a first screening colonoscopy, older patients are more likely to have a detection of adenomatous polyps and colorectal cancer (CRC), reveals a study.
Older age at first screening colonoscopy linked to higher risk of adenomas, CRC
25 Aug 2023
S-1 plus oxaliplatin on par with existing regimen for colorectal cancer treatment
Treatment with S-1, an oral fluoropyrimidine formulation similar to capecitabine, plus oxaliplatin (SOX) results in substantial improvements in overall response rate relative to capecitabine plus oxaliplatin (CapeOx) in patients with metastatic colorectal cancer, according to a Philippines study presented at the recent ESMO GI 2023.
S-1 plus oxaliplatin on par with existing regimen for colorectal cancer treatment
15 Aug 2023
Minimally invasive Whipple procedure possible with robotic surgical systems
The Whipple procedure, a complex surgery also known as pancreaticoduodenectomy, is the treatment of choice for patients with pancreatic cancer located at the head of the pancreas.
Minimally invasive Whipple procedure possible with robotic surgical systems
10 Aug 2023
Fosaprepitant dosing frequency makes no difference in CCRT-induced nausea, vomiting prevention
For patients undergoing concurrent chemoradiotherapy (CCRT), treatment with either weekly or every-3-weeks fosaprepitant helps reduce nausea and vomiting caused by CCRT, with no difference in the effect, as reported in a study.
Fosaprepitant dosing frequency makes no difference in CCRT-induced nausea, vomiting prevention
09 Aug 2023
Second-line avelumab works against dMMR/MSI metastatic colorectal cancer
Treatment with the immune checkpoint inhibitor avelumab in the second-line setting confers survival and disease control benefits in patients with deficient mismatch repair and/or microsatellite instability (dMMR/MSI) metastatic colorectal cancer (mCRC) when compared with standard treatment, with a favourable safety profile, according to the results of the phase II SAMCO-PRODIGE 54 trial.
Second-line avelumab works against dMMR/MSI metastatic colorectal cancer
09 Aug 2023
Experts call for early screening to lower colorectal cancer incidence
An expert-led public forum highlighted colorectal health awareness and early screening of people aged 45 and above, as key steps to reduce the burden of colorectal cancer (CRC) in Malaysia.